Jesse Berry, MD
Jesse Berry, MD, is the Director of Ocular Oncology and the Retinoblastoma Program at Children’s Hospital Los Angeles. She completed a fellowship at Children’s Hospital Los Angeles under the mentorship of Dr. Kim and A. Linn Murphree, MD, who founded the Retinoblastoma Program at Children’s Hospital Los Angeles. Dr. Berry’s retinoblastoma research is supported by the National Cancer Institute.
Retinoblastoma, Choroidal Melanoma, Ocular Oncology, Clinical Outcomes
Education
Harvard Medical School, Boston, MA, Doctor of Medicine
Memorial Sloan Kettering Cancer Center, Transitional Intern, New York, NY
Doheny Eye Institute, University of Southern California Ophthalmology, Los Angeles, CA
Children’s Hospital Los Angeles, University of Southern California, Ocular Oncology and Oculoplastic Surgery, Los Angeles, CA
Accomplishments
American Academy of ophthalmology, 2009-present
Association for Research in Vision & Ophthalmology, 2009-present
International Society of Ocular Oncology, 2008-present
American Society of Cataract and Refractive Surgery, 2012-present
Women in Ophthalmology, 2012-present
California Association of Eye Physicians and Surgeons, 2011-present
Los Angeles Society of Ophthalmology, 2011-present
Society of Heed Fellows, 2013-present
Harvard College Scholarship: Elizabeth Cary Agassiz Scholar, 2000-2004
Malcolm Kinsberg Scholarship, 2000-2004; Kappa Alpha Theta Foundation Scholarship, 2002
David Rockefeller Center of Latin American Studies Grant, 2003
Nevil & Louise Ford Scholarship Fund, 2004-2008
Harvard Medical International Initiatives in Research Grant, 2005
Center for Eye Research and Education McCleary Grant, 2007
Doheny Eye Institute Medical Knowledge Award, 2011
Starr Schulman Fellowship, 2012
Department of Health Services Innovation Grant, 2012
Heed Ophthalmic Foundation Fellow, 2013-2014
Society of Heed Fellows, 2013
University of Southern California Excellence in Resident Teaching Award, 2013
University of Southern California Excellence in Resident Teaching Award, 2014
University of Southern California Excellence in Resident Teaching Award, 2018
Publications
Berry JL, Jubran R, Kim JW, Wong KE, Almarzouki H*, Lee TC, Murphree AL. Long term Outcomes of Group D Eyes in Bilateral Retinoblastoma Patients Treated with Chemoreduction and Low-dose IMRT Salvage. Pediatr Blood Cancer. 60(4):688-93, 2013. PMID#22997170
Berry JL, Kogachi K*, Aziz HA, McGovern K, Zolfaghari E*, Murphree AL, Jubran R, Kim JW. Risk of Metastasis and Orbital Recurrence in Advanced Retinoblastoma Eyes Treated with Systemic Chemoreduction versus Primary Enucleation. Pediatr Blood Cancer. 64(4), 2017. PMID#28221729 Co-initiated the project, executed data collection, primary composer of manuscript
Berry JL, Bechtold M*, Shah S*, Zolfaghari E*, Reid M, Jubran R, Kim JW. Not all seeds are created equal: Seed Classification is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 124(12): 1817-25, 2017. PMID#28655537
Berry JL, Shah S*, Bechtold M*, Zolfaghari E*, Jubran R, Kim JW. Long-term Outcomes of Group D Retinoblastoma Eyes during the Intravitreal Melphalan Era. Pediatr Blood Cancer. 64(12), 2017. PMCID#28646513
Berry JL, Xu L, Murphree AL, Krishnan S, Stachelek K, Zolfoghari E*, McGovern K, Lee TC, Carlsson A, Kuhn P, Kim JK, Cobrinik D, Hicks J. Potential of Aqueous Humor as a Surrogate Biopsy for Retinoblastoma. JAMA Ophthalmol. 135(11): 1221-1230, 2017. PMID#29049475, PMCID#PMC5710399
Research
Jesse Berry, MD, and Liya Xu, PhD, are principal investigators of the Aqueous Humor Liquid Biopsy Laboratory.
Evaluation of the aqueous humor for tumor-derived genetic information and its application to prognosis and precision medicine for retinoblastoma patients. Investigating new methods of chemotherapy delivery for the treatment of Retinoblastoma. Evaluating treatment outcomes for Retinoblastoma eyes. This includes evaluation of treatment outcomes after systemic chemotherapy and the elucidation of factors present at diagnosis, which contribute to final visual outcome in eyes treated for retinoblastoma.
Media
Medical Xpress - Expert reviews the current state of retinoblastoma research
KOSU 91.7 Podcast - 'Focus: Black Oklahoma': FAFSA, Tulsa's Beyond Apology report, Retinoblastoma
ReachMD - CHLA Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study
KOST 103.5 FM - More than $300K Raised for Children's Hospital Los Angeles on Giving Tuesday
Science Daily - Eye on research: A new way to detect and study retinoblastoma
Jesse Berry, MD Discusses Precision Medicine for Retinoblastoma
KTLA - Giving Tuesday at Children's Hospital Los Angeles
KOST 103.5 - Ellen K hosts Giving Tuesday broadcast from Children's Hospital Los Angeles
4650 Sunset Blvd.
Los Angeles, CA 90027
United States